Mitochondrial disease patient motivations and barriers to participate in clinical trials

Abstract excerpt

BACKGROUND: Clinical treatment trials are increasingly being designed in primary mitochondrial disease (PMD), a phenotypically and genetically heterogeneous collection of inherited multi- system energy deficiency disorders that lack effective therapy. We sought to identify motivating factors and barriers to clinical trial participation in PMD. METHODS: A survey study was conducted in two independent mitochondrial...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Childhood Cancer Survivors' Quality of Life
• Share to Health Systems, Economic Evaluations, Quality of Life
• Share to Mitochondrial Function and Pathology